Michael P. Dube - 01 Mar 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
01 Mar 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 16:28:45 UTC
Previous filing
07 Jan 2025
Next filing
03 Jul 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Award $0 +14,000 +31% $0.000000 59,640 01 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.